StageGrant | IPO
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral-fluid collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests and other medical devices.
Missing: OraSure Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: OraSure Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing OraSure Technologies
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned OraSure Technologies in 1 CB Insights research brief, most recently on Jul 14, 2020.
Expert Collections containing OraSure Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OraSure Technologies is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting
OraSure Technologies Patents
OraSure Technologies has filed 20 patents.
The 3 most popular patent topics include:
- Molecular biology
- Experimental drugs
Latest OraSure Technologies News
Dec 1, 2022
Search jobs 01-Dec-2022 Global Rapid Microbiology Tests Market Report to 2030 - Featuring Abbott Laboratories, Alere, Danaher and Orasure Technologies Among Others - ResearchAndMarkets.com Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings. In the next few years the demand for rapid microbiology tests is expected to increase significantly in the emerging economies such as China and India. Companies Mentioned Sysmex Corporation The technology type studies for analyzing the overall rapid microbiology tests market are nucleic acid based tests, antibody based tests, biochemical tests, enzymatic tests, flow cytometry methods, polymerase chain reaction methods and impedance methods. This report also highlights information about end user segment, such as food and beverages industry, pharmaceutical industry, environmental sector, personal care products and others. Market size and forecast for each of these segments for the period 2020-2030 are provided in this study along with respective CAGRs for the forecast period 2022-2030 Market size and forecast for these regional and country level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2022-2030 are also included in this report, considering 2021 as the base year. Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global rapid microbiology tests market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global rapid microbiology tests market. This report concludes with company profiles section that highlights major information about the key players engaged in rapid microbiology tests market. Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings. In addition, rapid microbiology tests offer faster and more accurate methods to assist in the rapid diagnosis and treatment of patients or to provide safe and reliable food, water, and pharmaceuticals. The rapid microbiology tests have been broadly segmented into nucleic acid based tests, antibody based tests, biochemical tests, enzymatic tests, flow cytometry methods, polymerase chain reaction methods and impedance methods. Nucleic acid based tests held the largest share in the rapid microbiology market due to its wide application in the life science and food industry. Moreover, low cost and high speed would further fuel the market growth of nucleic acid based tests. The geographical segmentation of the global rapid microbiology tests market comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In base year 2021, North America accounted for the largest market in the rapid microbiology tests market due to the presence of major life science companies in the region. Moreover, North America enhanced government initiatives to regulate the rapid microbiological testing in the industrial and clinical setting has further assisted the growth of rapid microbiology tests market in the region. Asia Pacific is expected to grow at a highest rate during the forecast period due to the population growth in the region, increasing infectious diseases in the region. Rising investments by the major life science companies in the region would further fuel the growth of the rapid microbiology tests market in the region. Key questions answered in this report What are the key micro and macro environmental factors that are impacting the growth of Rapid Microbiology Tests market? What are the key investment pockets with respect to product segments and geographies currently and during the forecast period? Estimated forecast and market projections up to 2030. Which segment accounts for the fastest CAGR during the forecast period? Which market segment holds a larger market share and why? Are low and middle-income economies investing in the Rapid Microbiology Tests market? Which is the largest regional market for Rapid Microbiology Tests market? What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa? Which are the key trends driving Rapid Microbiology Tests market growth? Who are the key competitors and what are their key strategies to enhance their market presence in the Rapid Microbiology Tests market worldwide? Key Topics Covered:
OraSure Technologies Frequently Asked Questions (FAQ)
When was OraSure Technologies founded?
OraSure Technologies was founded in 1987.
Where is OraSure Technologies's headquarters?
OraSure Technologies's headquarters is located at 220 East First Street, Bethlehem.
What is OraSure Technologies's latest funding round?
OraSure Technologies's latest funding round is Grant.
How much did OraSure Technologies raise?
OraSure Technologies raised a total of $20M.
Who are the investors of OraSure Technologies?
Investors of OraSure Technologies include Bill & Melinda Gates Foundation.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.